Treace Medical Concepts (TMCI) EBITDA Margin Growth (1y) (2021 - 2026)
Treace Medical Concepts (TMCI) EBITDA Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -497.00 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 670.00 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 546.00 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 264.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 595.00 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 89.00 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -247.00 |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 146.00 |
| 10 | Treace Medical Concepts | 290.12 Mn | 244.50 Mn | 35.61 Mn | 286.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 286.00 |
| Mar 31, 2026 | -673.00 |
| Dec 31, 2025 | -918.00 |
| Sep 30, 2025 | 235.00 |
| Jun 30, 2025 | 1,228.00 |
| Mar 31, 2025 | 747.00 |
| Dec 31, 2024 | 1,060.00 |
| Sep 30, 2024 | 1,015.00 |
| Jun 30, 2024 | -1,699.00 |
| Mar 31, 2024 | -447.00 |
| Dec 31, 2023 | -387.00 |
| Sep 30, 2023 | -948.00 |
| Jun 30, 2023 | 871.00 |
| Mar 31, 2023 | -478.00 |
| Dec 31, 2022 | 971.00 |
| Sep 30, 2022 | -898.00 |
| Jun 30, 2022 | -2,021.00 |
| Mar 31, 2022 | -2,038.00 |
| Dec 31, 2021 | -3,182.00 |
| Sep 30, 2021 | -2,481.00 |